Literature DB >> 28608202

Zymography as a Research Tool in the Study of Matrix Metalloproteinase Inhibitors.

Zongli Ren1, Juanjuan Chen1, Raouf A Khalil2.   

Abstract

Matrix metalloproteinases (MMPs) are proteolytic enzymes that degrade various components of the extracellular matrix (ECM) and play a role in tissue remodeling. Changes in MMPs have been observed in cancer, connective tissue disorders, and vascular disease, and both endogenous tissue inhibitors of MMPs (TIMPs) and synthetic MMP inhibitors (MMPIs) have been evaluated as modulators of MMP activity in various biological systems. Zymography is a simple technique that is commonly used to assess MMP activity and the efficacy of MMPIs. Also, reverse zymography is a modified technique to study the activity of endogenous TIMPs. However, problems are often encountered during the zymography procedure, which could interfere with accurate assessment of MMP activity in control specimens, and thus make it difficult to determine the pathological changes in MMPs and their responsiveness to MMPIs. Simplified protocols for preparation of experimental solutions, tissue preparation, regular and reverse zymography procedures, and zymogram analysis are presented. Additional helpful tips to troubleshoot problems in the zymography technique and to enhance the quality of the zymograms should make it more feasible to determine the changes in MMPs and assess the efficacy of MMPIs in modulating MMP activity in various biological systems and pathological conditions.

Entities:  

Keywords:  Blood vessels; Extracellular matrix; Matrix metalloproteinase; TIMP; Uterus

Mesh:

Substances:

Year:  2017        PMID: 28608202      PMCID: PMC5527288          DOI: 10.1007/978-1-4939-7111-4_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  73 in total

1.  Characterization of the role of the "MT-loop": an eight-amino acid insertion specific to progelatinase A (MMP2) activating membrane-type matrix metalloproteinases.

Authors:  W R English; B Holtz; G Vogt; V Knäuper; G Murphy
Journal:  J Biol Chem       Date:  2001-09-12       Impact factor: 5.157

2.  Design and therapeutic application of matrix metalloproteinase inhibitors.

Authors:  M Whittaker; C D Floyd; P Brown; A J Gearing
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

Review 3.  Assays of matrix metalloproteinases (MMPs) activities: a review.

Authors:  Carine Lombard; Joëlle Saulnier; Jean Wallach
Journal:  Biochimie       Date:  2005 Mar-Apr       Impact factor: 4.079

4.  Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.

Authors:  Yonghan Hu; Jason S Xiang; Martin J DiGrandi; Xuemei Du; Manus Ipek; Leif M Laakso; Jianchang Li; Wei Li; Thomas S Rush; Jean Schmid; Jerauld S Skotnicki; Steve Tam; Jennifer R Thomason; Qin Wang; Jeremy I Levin
Journal:  Bioorg Med Chem       Date:  2005-10-10       Impact factor: 3.641

5.  Unraveling hidden regulatory sites in structurally homologous metalloproteases.

Authors:  Yael Udi; Marco Fragai; Moran Grossman; Simon Mitternacht; Rina Arad-Yellin; Vito Calderone; Maxime Melikian; Mirco Toccafondi; Igor N Berezovsky; Claudio Luchinat; Irit Sagi
Journal:  J Mol Biol       Date:  2013-04-11       Impact factor: 5.469

Review 6.  Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

Authors:  Zorina S Galis; Jaikirshan J Khatri
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

7.  Functional interplay between type I collagen and cell surface matrix metalloproteinase activity.

Authors:  S M Ellerbroek; Y I Wu; C M Overall; M S Stack
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

8.  A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth.

Authors:  Juho Suojanen; Tuula Salo; Erkki Koivunen; Timo Sorsa; Emma Pirilä
Journal:  Cancer Biol Ther       Date:  2009-12-19       Impact factor: 4.742

Review 9.  Tissue inhibitors of metalloproteinases.

Authors:  Gillian Murphy
Journal:  Genome Biol       Date:  2011-11-11       Impact factor: 13.583

10.  Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities.

Authors:  Margaret W Ndinguri; Manishabrata Bhowmick; Dorota Tokmina-Roszyk; Trista K Robichaud; Gregg B Fields
Journal:  Molecules       Date:  2012-11-30       Impact factor: 4.411

View more
  7 in total

1.  In Vitro Models to Study Angiogenesis and Vasculature.

Authors:  Ralph Francescone; Débora Barbosa Vendramini-Costa
Journal:  Methods Mol Biol       Date:  2022

2.  MDM2 Derived from Dedifferentiated Liposarcoma Extracellular Vesicles Induces MMP2 Production from Preadipocytes.

Authors:  Lucia Casadei; Federica Calore; Danielle A Braggio; Abeba Zewdu; Ameya A Deshmukh; Paolo Fadda; Gonzalo Lopez; Martin Wabitsch; Chi Song; Jennifer L Leight; Valerie P Grignol; Dina Lev; Carlo M Croce; Raphael E Pollock
Journal:  Cancer Res       Date:  2019-08-06       Impact factor: 12.701

3.  Antitumor potential of new low molecular weight antioxidative preparations from the white rot fungus Cerrena unicolor against human colon cancer cells.

Authors:  Anna Matuszewska; Dawid Stefaniuk; Magdalena Jaszek; Mateusz Pięt; Adrian Zając; Łukasz Matuszewski; Iga Cios; Marcin Grąz; Roman Paduch; Renata Bancerz
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

4.  Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment.

Authors:  Aditya N Bade; JoEllyn M McMillan; Yutong Liu; Benson J Edagwa; Howard E Gendelman
Journal:  Mol Neurobiol       Date:  2021-08-14       Impact factor: 5.590

5.  Differential expression of aqueous humor microRNAs in central retinal vein occlusion and its association with matrix metalloproteinases: a pilot study.

Authors:  Eun Hee Hong; Mina Hwang; Hyoseon Yu; Hyun-Hee Park; Heeyoon Cho; Seong-Ho Koh; Yong Un Shin
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

6.  Inhibition of Matrix Metalloproteinase 9 Activity Promotes Synaptogenesis in the Hippocampus.

Authors:  Ahmad Salamian; Diana Legutko; Klaudia Nowicka; Bogna Badyra; Paulina Kaźmierska-Grębowska; Bartosz Caban; Tomasz Kowalczyk; Leszek Kaczmarek; Anna Beroun
Journal:  Cereb Cortex       Date:  2021-07-05       Impact factor: 5.357

7.  Cirsiliol Suppressed Epithelial to Mesenchymal Transition in B16F10 Malignant Melanoma Cells through Alteration of the PI3K/Akt/NF-κB Signaling Pathway.

Authors:  Priyanka Prasad; Andrea Vasas; Judit Hohmann; Anupam Bishayee; Dona Sinha
Journal:  Int J Mol Sci       Date:  2019-01-31       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.